குறியிடப்பட்டது
  • ஜெ கேட் திறக்கவும்
  • கல்வி விசைகள்
  • ஆராய்ச்சி பைபிள்
  • சீனாவின் தேசிய அறிவு உள்கட்டமைப்பு (CNKI)
  • சர்வதேச வேளாண்மை மற்றும் உயிரியல் அறிவியல் மையம் (CABI)
  • RefSeek
  • ஹம்டார்ட் பல்கலைக்கழகம்
  • EBSCO AZ
  • OCLC- WorldCat
  • CABI முழு உரை
  • பப்ளான்கள்
  • மருத்துவக் கல்வி மற்றும் ஆராய்ச்சிக்கான ஜெனீவா அறக்கட்டளை
  • கூகுள் ஸ்காலர்
இந்தப் பக்கத்தைப் பகிரவும்
ஜர்னல் ஃப்ளையர்
Flyer image

சுருக்கம்

Factors Determining Physicians’ Decision Making In Treatment and the Outcomes of Nosocomial Diarrhea in a Tertiary Care Hospital: A Prospective Cohort

Pimkamon Siengwattana1, Natthanan Poovipirom1, Methee Chayakulkeeree1, Pattarachai Kiratisin2 and Monthira Maneerattanaporn

Background: Patients with nosocomial diarrhea (ND) are empirically treated as if they have Clostridium-difficileassociated diarrhea (CDAD), even if their stool tests are negative for C. difficile. We determined the incidence, risk factors, and treatment outcomes of patients with ND in Siriraj Hospital.

Methods: All patients with ND were enrolled. Demographic data, clinical and laboratory and stool for C. difficile toxin were collected including severity and outcomes of ND. Descriptive analysis was performed using mean ± SD/ median ± IQR for continuous data and frequency for categorical data. χ2/Fisher’s exact tests were used to compare groups. Predictors that might determine the decision to prescribe empirical treatment were identified using regression analysis.

Results: We enrolled 105 patients (mean age 67 years), and 89.5% were non-CDAD. During ND development, 95.7% received antibiotics and 3.2% chemotherapy. Eleven patients had CDAD. Common findings included: fever 42.6%, abdominal pain and hemodynamic instability 7.4%; 11.7% had blood cells in their stools and 85.1% had low serum albumin. Median white blood cell count and serum creatinine were 11-880 cells/mm3 and 1.4 mg/dl, respectively. CDAD treatment was prescribed in 48.9% regardless of the toxin result; 95.7% received metronidazole and 4.3% vancomycin. Response outcomes did not differ significantly between the two groups.

Conclusion: Incidence of ND was 4.7%, and 10.6% of these had CDAD. 43.8% of patients with ND were treated as CDAD although they were negative for C. difficile toxin. There were no significant differences in clinical and laboratory features and outcomes between treated and untreated groups. Further study is needed to determine if empirical treatment of CDAD is justified in all cases of ND.

மறுப்பு: இந்த சுருக்கமானது செயற்கை நுண்ணறிவு கருவ